Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Daiichi Sankyo Co. Ltd.
DescriptionToll-like receptor 4 (TLR4) inhibitor
Molecular Target Toll-like receptor 4 (TLR4)
Mechanism of ActionToll-like receptor 4 (TLR4) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSepsis
Indication DetailsTreat sepsis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today